Table 2.
Characteristics by Surgical Intervention (n = 179)
| Surgical Intervention | SB (N=50) | PPV (N=98) | PPV/SB (N=31) | P-values |
|---|---|---|---|---|
| Age, mean (SD) | 50.0 (16.3) | 62.5 (11.9) | 54.3 (11.8) | <0.001* |
| Follow Up, mean (SD) | 19.8 (12.7) | 19.4 (13.7) | 21.0 (14.3) | 0.85 |
| Male (%) | 35 (70.0) | 60 (61.2) | 21 (67.7) | 0.53 |
| Female (%) | 15 (30.0) | 38 (38.8) | 10 (32.3) | |
| Right Eye (%) | 30 (60.0) | 53 (54.1) | 17 (54.8) | 0.78 |
| Left Eye (%) | 20 (40.0) | 45 (45.9) | 14 (45.2) | |
| Duration of Symptoms, median days (range) | 14 (1–365) | 10 (1–180) | 14 (2–180) | 0.86 |
| Myopic (%) | 34 (68.0) | 60 (61.2) | 15 (48.4) | 0.21 |
| Non-Myopic (%) | 16 (32.0) | 38 (38.8) | 16 (51.6) | |
| Phakic (%) | 44 (88.0) | 46 (46.9) | 23 (74.2) | <0.001* |
| Pseudophakic (%) | 6 (12.0) | 52 (53.1) | 8 (25.8) | |
| Single Tear (%) | 23 (46.0) | 39 (39.8) | 13 (41.9) | 0.95 |
| >1 Tear (%) | 25 (50.0) | 56 (57.1) | 17 (54.8) | |
| No Tear (%) | 2 (4.0) | 3 (3.1) | 1 (3.2) | |
| Macula-On (%) | 14 (28.0) | 33 (33.7) | 8 (25.8) | 0.63 |
| Macula-Off (%) | 36 (72.0) | 65 (66.3) | 23 (74.2) | |
| Preoperative BCVA, logMAR mean | 0.89 | 1.09 | 1.39 | 0.08 |
Notes: *Indicates significant difference between the designated values in the row. Data was interpreted using ANOVA with a significance level of 0.05.
Abbreviations: BCVA, Best-Corrected Visual Acuity; logMAR, logarithm of minimum angle of resolution.